-
1 Comment
Novanta Inc is currently in a long term uptrend where the price is trading 7.5% above its 200 day moving average.
From a valuation standpoint, the stock is 67.9% cheaper than other stocks from the Technology sector with a price to sales ratio of 8.1.
Novanta Inc's total revenue sank by 7.6% to $147M since the same quarter in the previous year.
Its net income has increased by 37.3% to $13M since the same quarter in the previous year.
Finally, its free cash flow grew by 32.4% to $43M since the same quarter in the previous year.
Based on the above factors, Novanta Inc gets an overall score of 4/5.
| Sector | Technology |
|---|---|
| Industry | Scientific & Technical Instruments |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | US67000B1044 |
| Market Cap | 4B |
|---|---|
| Beta | 1.63 |
| PE Ratio | 80.03 |
| Target Price | 160 |
| Dividend Yield | None |
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NOVT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026